Arcutis appoints L. Todd Edwards as Chief Commercial Officer; Ayisha Jeter promoted

Arcutis Biotherapeutics, Inc.

Edwards joins from Incyte with 25+ years in dermatology/immunology at UCB and AbbVie.
He will lead ZORYVE cream launch for plaque psoriasis and prepare for future indications.
Ayisha Jeter promoted to SVP Marketing and Market Access, reporting to Edwards.
Edwards receives $500,016 base salary, 45% target bonus, equity grants of 240K options, 60K RSUs, 60K PSUs.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

L. Todd Edwards

Chief Commercial Officer

ARQT · Arcutis Biotherapeutics, Inc.

Effective: 2023-09-27
Filed: September 27, 2023, 7:59 PM ET

On September 27, 2023, Arcutis Biotherapeutics, Inc. (the “Company” or “Arcutis”) announced the appointment of L. Todd Edwards as the Company’s Chief Commercial Officer, effective as of September 27, 2023.

Role change

Ayisha Jeter

Senior Vice President, Marketing and Market Access

ARQT · Arcutis Biotherapeutics, Inc.

Effective: 2023-09-27
Successor: L. Todd Edwards
Filed: September 27, 2023, 7:59 PM ET

In connection with the appointment of Mr. Edwards, Ms. Jeter will be promoted to Senior Vice President, Marketing and Market Access, effective as of September 27, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

L. Todd Edwards was appointed as Chief Commercial Officer at Arcutis Biotherapeutics, Inc..

Action: appointed
Role: Chief Commercial Officer

Exact text from the filing

On September 27, 2023, Arcutis Biotherapeutics, Inc. (the “Company” or “Arcutis”) announced the appointment of L. Todd Edwards as the Company’s Chief Commercial Officer, effective as of September 27, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Ayisha Jeter changed role as Senior Vice President, Marketing and Market Access at Arcutis Biotherapeutics, Inc..

Action: promoted
Role: Senior Vice President, Marketing and Market Access

Exact text from the filing

In connection with the appointment of Mr. Edwards, Ms. Jeter will be promoted to Senior Vice President, Marketing and Market Access, effective as of September 27, 2023.

View on SEC.gov

Arcutis Biotherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001787306-23-000109

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.